MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5152/tjg.2026.25611

Медицинская библиотека · The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2026

Development and Validation of a Machine Learning-Based Prediction Model for Cardiovascular Disease in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease.

Wang Li-Huan

СтатьяВалидационное исследованиеПеревод в очереди

Аннотация

BACKGROUND/AIM: Metabolic dysfunction-associated fatty liver disease (MAFLD) is strongly associated with increased cardiovascular disease (CVD) risk. However, traditional cardiovascular risk assessment tools may inadequately capture the complex pathophysiology linking hepatic and CVD in MAFLD patients. This study aimed to develop and validate machine learning models to predict CVD risk in MAFLD patients.

MATERIALS AND

METHODS

This cross-sectional study analyzed NHANES 2017-2023 data, with participants randomly split into training (70%) and validation (30%) sets.

RESULTS

A total of 6828 adults with MAFLD were included (13.1% with prevalent CVD). Least Absolute Shrinkage and Selection Operator regression identified 14 key predictors, with age, nonalcoholic fatty liver disease Fibrosis Score (NFS), and albumin emerging as the most influential. Critically, liver-specific markers (NFS: mean |SHAP| = 0.0299; albumin: 0.0289) demonstrated superior predictive capacity compared to traditional cardiovascular risk factors (hypertension: 0.0145; diabetes: 0.0107; smoking: 0.0035). SHapley Additive exPlanations analysis revealed that older age, higher NFS (particularly > -1.0), and lower albumin (<3.5 g/dL) were the strongest drivers of CVD risk, with NFS showing clear threshold effects.

CONCLUSION

The findings confirm that traditional cardiovascular risk assessment approaches are insufficient for MAFLD patients, as liver-specific markers-particularly hepatic fibrosis (NFS) and liver synthetic function (albumin)-dominated cardiovascular risk prediction over conventional risk factors (hypertension, diabetes, smoking). This paradigm shift underscores the necessity of integrated liver-heart assessment in MAFLD and supports routine hepatic fibrosis evaluation for cardiovascular risk stratification. The model demonstrates immediate clinical applicability through existing electronic health records, enabling early identification of high-risk patients for targeted preventive interventions.

Для цитирования: Wang Li-Huan. Development and Validation of a Machine Learning-Based Prediction Model for Cardiovascular Disease in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease.. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology. 2026. DOI: 10.5152/tjg.2026.25611.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.